Nexavar by Bayer is a drug endorsed for the treatment of essential kidney tumor (progressed renal cell carcinoma) and propelled essential liver growth (hepatocellular carcinoma). Its non specific name is Sorafenib. It has both US FDA and European Commision endorsement for use in the treatment of cutting edge renal disease and liver tumor. Sorafenib is a little sub-atomic inhibitor of a few Tyrosine protein kinases (VEGFR and PDGFR) and Raf kinases. It is available in 200 mg dose and 60 tablets/bottle Packaging .
Producer : Bayer
Indications :
Conceivable Side Effects :
Here are some of the Indications many-however not all-individuals get when they take Nexavar :